Molecular aspects of diabetes mellitus: Resistin, microRNA, and exosome
- 23 August 2017
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 119 (2) , 1257-1272
Abstract
Diabetes mellitus (DM) is known as one of important common endocrine disorders which could due to deregulation of a variety of cellular and molecular pathways. A large numbers studies indicated that various pathogenesis events including mutation, serin phosphorylation, and increasing/decreasing expression of many genes could contribute to initiation and progression of DM. Insulin resistance is one of important factors which could play critical roles in DM pathogenesis. It has been showed that insulin resistance via targeting a sequence of cellular and molecular pathways (eg, PI3 kinases, PPARγ co‐activator‐1, microRNAs, serine/threonine kinase Akt, and serin phosphorylation) could induce DM. Among of various factors involved in DM pathogenesis, microRNAs, and exosomes have been emerged as effective factors in initiation and progression of DM. A variety of studies indicated that deregulation of these molecules could change behavior of various types of cells and contribute to progression of DM. Resistin is other main factor which is known as signal molecule involved in insulin resistance. Multiple lines evidence indicated that resistin exerts its effects via affecting on glucose metabolism, inhibition of fatty acid uptake and metabolism with affecting on a variety of targets such as CD36, fatty acid transport protein 1, Acetyl‐CoA carboxylase, and AMP‐activated protein kinase. Here, we summarized various molecular aspects are associated with DM particularly the molecular pathways involved in insulin resistance and resistin in DM. Moreover, we highlighted exosomes and microRNAs as effective players in initiation and progression of DM.Keywords
This publication has 159 references indexed in Scilit:
- Leptin, resistin and visfatin: the missing link between endocrine metabolic disorders and immunityEuropean Journal of Medical Research, 2013
- Microvesicles/exosomes as potential novel biomarkers of metabolic diseasesDiabetes, Metabolic Syndrome and Obesity, 2012
- MicroRNAs in β-Cell Biology, Insulin Resistance, Diabetes and Its ComplicationsDiabetes, 2011
- Integration of microRNA changes in vivo identifies novel molecular features of muscle insulin resistance in type 2 diabetesGenome Medicine, 2010
- miR-375 maintains normal pancreatic α- and β-cell massProceedings of the National Academy of Sciences, 2009
- Association of Variants in RETN With Plasma Resistin Levels and Diabetes-Related Traits in the Framingham Offspring StudyDiabetes, 2009
- Obesity in psoriasis: leptin and resistin as mediators of cutaneous inflammationBritish Journal of Dermatology, 2008
- Adipocytokines: mediators linking adipose tissue, inflammation and immunityNature Reviews Immunology, 2006
- Critical nodes in signalling pathways: insights into insulin actionNature Reviews Molecular Cell Biology, 2006
- A pancreatic islet-specific microRNA regulates insulin secretionNature, 2004